The novel trihydro(mercaptoazolyl)borates Na[H(3)B(tim(Me))] (L(1)) (tim(Me) = 2-mercapto-1-methylimidazolyl), Na[H(3)B(tim(Bupip))] (L(2)) (tim(Bupip) = 1-[4-((2-methoxyphenyl)-1-piperazinyl)butyl]-2-mercaptoimidazolyl), and Na[H(3)B(bzt)] (L(3)) (bzt = 2-mercaptobenzothiazolyl) were synthesized by reaction of NaBH(4) with the corresponding azole. Ligands L(1)-L(3) represent a new class of light and soft scorpionates that stabilizes the [M(CO)(3)](+) core (M = (99)Tc, Re) by formation of the complexes fac-[M{kappa(3)-H(mu-H)(2)B(tim(Me))}(CO)(3)] (M = (99)Tc (1), Re (2)), fac-[Re{kappa(3)-H(mu-H)(2)B(tim(Bupip))}(CO)(3)] (3), and fac-[Re{kappa(3)-H(mu-H)(2)B(bzt)}(CO)(3)] (4), respectively. The soft scorpionates are coordinated to the metal in unique (kappa(3)-H, H', S) fashion, as confirmed by X-ray crystallography of 1, 2, and 4. These complexes with bis-agostic hydride coordination are formed in aqueous solution with the two hydrides replacing two coordinating aquo ligands. The agostic hydrogen atoms were located directly, confirming an unprecedented donor atom set combining one sulfur and two hydrogen atoms. Preliminary studies have shown the possibility of preparing some of these complexes at the no carrier added level ((99m)Tc), under conditions as required in radiopharmaceutical preparation. Due to their lipophilicity, small-size, and easy functionalization with adequate biomolecules, the trihydro(mercaptoazolyl)borate technetium tricarbonyl complexes are suitable for the design of CNS receptor ligand radiopharmaceuticals as exemplified with 3, comprising a pendant serotonergic 5-HT(1A) ligand. The integrated design of radiopharmaceuticals involving a bis-agostic scorpionate ligand is demonstrated by the synthesis of 4, with an integrated benzothiazolyl fragment for the recognition of beta-amyloid plaques.